Serial #99257154
LIVE

Serial Number

99257154

Owner

Enveda Therapeutics, Inc.

Attorney

Christina M. Licursi

First Use Date

Nov 12, 2024

Filing Date

Jun 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99257154 Trademark

Serial Number: 99257154

Serial #99257154 is a trademark filed by Enveda Therapeutics, Inc. on June 27, 2025. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products). The application is currently pending registration.

Owner Contact Info

Enveda Therapeutics, Inc. (13 trademarks)

5700 Flatiron Parkway
Boulder, CO 80301

Entity Type: 03

Trademark Details

Filing Date

June 27, 2025

Registration Date

Not Registered

First Use Anywhere

November 12, 2024

First Use in Commerce

November 12, 2024

Published for Opposition

March 10, 2026

Goods & Services

Agricultural, horticultural and forestry products, namely, seeds and bulbs for agricultural and horticultural purposes, seedlings, live plant grafts, and plugs being seedlings or live rooted plant cuttings and planting soil sold as a unit; raw and unprocessed agricultural and horticultural products, namely, plant biomass being organic matter derived from live plants; natural live plants, rootstocks and flowers; live bulbs, seedlings, plant bulb divisions in the nature of live plant cuttings being parts of live plants, micropropagated seeds for agricultural and horticultural purposes, tissue-cultured seedlings, and seeds for planting for agricultural and horticultural purposes; agricultural and aqua-cultural crops, namely, crop seeds for agricultural and horticultural purposes and live plant cuttings and divisions being parts of live plants; horticulture and forestry products, namely, unprocessed seeds for planting for aqua-cultural and forestry use

Cosmetic skin and hair care preparations for use in connection with the improvement in the appearance of human skin

Pharmaceutical preparations for suppressing tumors and treatment of cancer; pharmaceuticals for use in the treatment of immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders; house mark for a full line of veterinary preparations for treatment of cancer, immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders for use in connection with companion and farm animals

Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract scientific research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals, namely, pharmaceutical research and development; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; Scientific and technological services, namely, scientific research and design for others in the field of pharmaceuticals and conducting and evaluating clinical trials for others; software as a service (SaaS) services featuring software enabling users to diagnose medical conditions, prescribe medical treatment and prescriptions, design clinical trials and forecast clinical trial results, search for clinical trial patients, analyze data, and develop pharmaceutical products and chemical compounds

Plant growth promoters and plant growth regulators in the nature of plant hormones for promoting plant growth, and biological soil and plant soil amendments for use in agriculture and horticulture; seed microbial inoculants and soil inoculants for use in agriculture and horticulture; biochemicals, namely, biological signal molecules in the nature of agricultural and horticultural chemicals, except fungicides, herbicides, insecticides and parasiticides, namely, natural and synthetic plant hormones, biological fertilizers, granulated fertilizers, and chemical additives for use in the manufacture of pesticides, insecticides, herbicides, biological pesticides, biological insecticides, and granulated pesticides that improve plant health and enhance growth of agricultural and horticultural crops; chemicals used in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides, namely seed treatment preparations; fertilizers for agricultural, domestic, horticultural, ornamental and commercial use; chemical preparations for the treatment of seeds and plants for agricultural use

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 13, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 13, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 13, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 13, 2026 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 13, 2026 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 10, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 10, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 10, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 10, 2026 CNEA
EXAMINER'S AMENDMENT ENTERED
Feb 10, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 10, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 10, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 10, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 6, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 27, 2025 MAFR
NEW APPLICATION ENTERED
Jun 27, 2025 NWAP